{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:00Z","timestamp":1761609900274},"reference-count":28,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.autrev.2014.01.016","type":"journal-article","created":{"date-parts":[[2014,1,12]],"date-time":"2014-01-12T01:15:24Z","timestamp":1389489324000},"page":"363-366","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diagnosis and classification of sporadic inclusion body myositis (sIBM)"],"prefix":"10.1016","volume":"13","author":[{"given":"M.","family":"Catal\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Selva-O'Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.01.016_bb0005","series-title":"Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology\/edited by the Gaetano Conte Academy for the study of striated muscle diseases","article-title":"Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul\/Turkey: a muscle biopsy based survey","volume":"30","author":"Oflazer","year":"2011"},{"key":"10.1016\/j.autrev.2014.01.016_bb0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","article-title":"Epidemiology of inclusion body myositis in the Netherlands: a nationwide study","volume":"55","author":"Badrising","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.016_bb0015","first-page":"554","article-title":"Increase in number of sporadic inclusion body myositis (sIBM) in Japan","volume":"259","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0020","first-page":"850","article-title":"Prevalence and diagnosis of sporadic inclusion body myositis (sIBM) in Western Australia","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2014.01.016_bb0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis\u2013diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0035","series-title":"Laboratory investigation; a journal of technical methods and, pathology","first-page":"240","article-title":"Inclusion body myositis","volume":"25","author":"Yunis","year":"1971"},{"key":"10.1016\/j.autrev.2014.01.016_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","article-title":"Inflammatory myopathies with mitochondrial pathology and protein aggregates","volume":"278","author":"Temiz","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2014.01.016_bb0045","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1074\/jbc.275.12.8703","article-title":"Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2","volume":"275","author":"Choi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2014.01.016_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mus.20652","article-title":"Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy","volume":"35","author":"Selva-O'Callaghan","year":"2007","journal-title":"Muscle & nerve."},{"key":"10.1016\/j.autrev.2014.01.016_bb0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","article-title":"HLA associations with inclusion body myositis","volume":"98","author":"Garlepp","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0060","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.5858\/2007-131-1070-MHCCIA","article-title":"Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies","volume":"131","author":"Jain","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.autrev.2014.01.016_bb0065","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1212\/01.wnl.0000192108.02654.ac","article-title":"Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?","volume":"66","author":"Murphy","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.016_bb0070","doi-asserted-by":"crossref","first-page":"536231","DOI":"10.1155\/2013\/536231","article-title":"Inclusion-body myositis associated with Alzheimer's disease","volume":"2013","author":"Levacic","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1016\/j.autrev.2014.01.016_bb0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-008-0449-0","article-title":"Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains","volume":"116","author":"Askanas","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0080","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","article-title":"Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments","volume":"48","author":"Mendell","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2014.01.016_bb0090","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1523\/JNEUROSCI.5894-09.2010","article-title":"TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP\/p97","volume":"30","author":"Ritson","year":"2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.autrev.2014.01.016_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/WCO.0b013e328357f211","article-title":"Pathogenesis and therapy of inclusion body myositis","volume":"25","author":"Greenberg","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0100","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43 KDa muscle protein in inclusion body myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2014.01.016_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle & nerve."},{"key":"10.1016\/j.autrev.2014.01.016_bb0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0025-7753(07)72561-7","article-title":"Inclusion-body myositis associated with systemic sclerosis","volume":"128","author":"Bielsa","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.autrev.2014.01.016_bb0115","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.01.016_bb0120","doi-asserted-by":"crossref","first-page":"e46709","DOI":"10.1371\/journal.pone.0046709","article-title":"Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis","volume":"7","author":"Ray","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2014.01.016_bb0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0130","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1002\/art.37692","article-title":"Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and beta-amyloid in the muscle","volume":"64","author":"Zschuntzsch","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.01.016_bb0135","first-page":"246","article-title":"Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features","volume":"25","author":"Quartuccio","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.01.016_bb0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11926-012-0248-4","article-title":"Exercise in inflammatory myopathies, including inclusion body myositis","volume":"14","author":"Alexanderson","year":"2012","journal-title":"Curr Rheumatol Rep"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T04:02:37Z","timestamp":1648008157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":28,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1568997214000287"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.016","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and classification of sporadic inclusion body myositis (sIBM)","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}